Buchumschlag

No QTcF Prolongation with Sepiapterin: Results From a Thorough QT Study in Healthy Subjects at Therapeutic and Supratherapeutic Doses

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Lan Gao, Hongqi Xue, Borje Darpo, Kimberly Ingalls, Diksha Kaushik, Neil Smith, Ronald Kong, Lee Golden
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	The Journal of Clinical Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers
von: Eugenio Mercuri, et al.
Veröffentlicht: (2026)

Lack of Concentration‐QTc Relationship and Cardiac Risk With Vatiquinone Therapeutic and Supratherapeutic Doses
von: Lucy Lee, et al.
Veröffentlicht: (2024)

Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1‐phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study
von: Borje Darpo, et al.
Veröffentlicht: (2024)

Concentration‐QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT study
von: Wei Yin, et al.
Veröffentlicht: (2024)

The Impact of QT‐Prolonging Medications and Drug–Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case‐Crossover Study
von: Hsiu‐Ting Chien, et al.
Veröffentlicht: (2024)

No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration–QTc Modeling Assessment
von: Mikael Sunnåker, et al.
Veröffentlicht: (2025)

Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of Vatiquinone
von: Lucy Lee, et al.
Veröffentlicht: (2024)

Pacritinib Impact on QT Interval: Results of a Thorough QT Study and Post Hoc Analysis of Prospective Clinical Trial Data
von: Sarah A. Buckley, et al.
Veröffentlicht: (2026)

Evaluation of the Effect of Momelotinib on Cardiac Repolarization: A Thorough QT Study
von: Georgios Vlasakakis, et al.
Veröffentlicht: (2025)

A Randomized Thorough QT Trial Using Concentration‐QT Analysis to Evaluate the Effects of Centanafadine on Cardiac Repolarization
von: Osman S. Turkoglu, et al.
Veröffentlicht: (2025)

A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants
von: Shichang Miao, et al.
Veröffentlicht: (2024)

Chat GPT and the Challenges to Detect Potential Drug–Drug Interactions Related to QT Prolongation
von: Emanuel Raschi, et al.
Veröffentlicht: (2025)

Ethnic Bridging of Votoplam, a HTT Gene Splicing Modifier, Using Pharmacokinetic Comparison Between Caucasian and Japanese Subjects
von: Lucy Lee, et al.
Veröffentlicht: (2026)

Bioequivalence and Food Effect Assessment of Eltrombopag Olamine Tablets in Healthy Chinese Subjects: An Open, Randomized, Single‐Dose, and Two‐Period Crossover Study
von: Jingyan Wang, et al.
Veröffentlicht: (2024)

Establishing the Exposure‐QT Relationship During Bedaquiline Treatment Using a Time‐Varying Tuberculosis‐Specific Correction Factor (QTcTBT)
von: Thanakorn Vongjarudech, et al.
Veröffentlicht: (2025)

A Single Dose, Randomized, Open‐Label, Cross‐Over Bioequivalence Study of Budesonide Pressurized Metered‐Dose Inhaler in Healthy Chinese Subjects
von: Kai Huang, et al.
Veröffentlicht: (2025)

Mass Balance and Metabolite Profile after Single and Multiple Oral Doses of Pritelivir in Healthy Subjects
von: Susanne Bonsmann, et al.
Veröffentlicht: (2024)

Weaning off ThoroughQTStudies
von: Mai Mehanna, et al.
Veröffentlicht: (2024)

Concentration‐QTc Modeling of the DPP‐4 Inhibitor HSK7653 in a First‐in‐Human Study of Chinese Healthy Volunteers
von: Xiaoxu Wang, et al.
Veröffentlicht: (2024)

Comparison of Anti‐Hepatitis A Antibody Pharmacokinetics in Healthy Australian Subjects Receiving Standard or Weight‐Based Dosing of Polyvalent Immunoglobulin
von: Megan K Young, et al.
Veröffentlicht: (2024)

Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes
von: Ola Nordqvist, et al.
Veröffentlicht: (2025)

Pharmacokinetics of Nitazoxanide Dry Suspensions After Single Oral Doses in Healthy Subjects: Food Effects Evaluation and Bioequivalence Study
von: Chenning Zhang, et al.
Veröffentlicht: (2024)

Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study
von: Junyu Xu, et al.
Veröffentlicht: (2024)

Population Pharmacokinetics of Dapoxetine in Healthy Chinese Male Subjects
von: Libin Pu, et al.
Veröffentlicht: (2025)

Single‐Dose Pharmacokinetics of Intranasal Levetiracetam in Healthy Dogs
von: Jessica L. Wagner, et al.
Veröffentlicht: (2026)

Structure‐Based Prediction of QT Prolongation Risk Using Graph Neural Networks: An Integrative Approach Combining In Vitro hERG Assays and Pharmacovigilance Data
von: Tomoyuki Enokiya, et al.
Veröffentlicht: (2026)

Concentration–QTc Modeling to Support Clinical Development of Fezolinetant
von: Jace C. Nielsen, et al.
Veröffentlicht: (2025)

Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed‐Dose Combination Product: Phase 1 Results in Healthy Pre‐ and Postmenopausal Women
von: Mong‐Jen Chen, et al.
Veröffentlicht: (2024)

A Bioequivalence Study of Azilsartan in Healthy Chinese Subjects
von: Xiaobei Liu, et al.
Veröffentlicht: (2024)

Effects of High‐ and Low‐Fat Meals on the Bioavailability and Pharmacokinetics of Votoplam, a HTT Gene Splicing Modifier
von: Lucy Lee, et al.
Veröffentlicht: (2025)

Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care
von: Anne Paulien Langermans, et al.
Veröffentlicht: (2026)

Bioequivalence and Tolerability of 2 Lurasidone Formulations: A Randomized, Single‐Dose, 2‐Period, Crossover Study in Healthy Chinese Subjects Under Fasting and Fed Conditions
von: Hengyi Yu, et al.
Veröffentlicht: (2025)

New Ustekinumab Biosimilar Candidate FYB202: Pharmacokinetic Equivalence Demonstrated in a Randomized, Double‐Blind, Parallel‐Group, Single‐Dose Trial in Healthy Subjects
von: Sigrid Balser, et al.
Veröffentlicht: (2024)

The Efficacy, Effectiveness, and Efficiency of Integrated QTc Assessment: Rationalizing Approaches to New Drug Modalities
von: Matthew M. Abernathy, et al.
Veröffentlicht: (2024)

Comparison of the Pharmacokinetics of Three Budesonide Formulations in Healthy Chinese Subjects
von: Tengrui Yin, et al.
Veröffentlicht: (2025)

Bioequivalence Study of Bedaquiline Fumarate Tablets in Healthy Chinese Subjects
von: Man Yang, et al.
Veröffentlicht: (2025)

Population Pharmacokinetics of Oral Gecacitinib in Healthy Subjects and Patients with Autoimmune and Inflammatory Diseases
von: Qingheng Meng, et al.
Veröffentlicht: (2026)

Single‐Dose Pharmacokinetic Assessment of TNX‐102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open‐Label Studies in Healthy Volunteers
von: Bruce L Daugherty, et al.
Veröffentlicht: (2026)

Pharmacokinetics, Safety, and Tolerability of Single‐Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double‐Blind, Phase 1 Studies
von: Naihan Chen, et al.
Veröffentlicht: (2025)

Pharmacokinetics and Safety of a Single Subcutaneous or Intramuscular Dose of Ketamine in Healthy Horses
von: Ana Rangel, et al.
Veröffentlicht: (2025)